RDTCF (Rapid Dose Therapeutics) Asset Turnover : 0.29 (As of Nov. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Rapid Dose Therapeutics's Revenue for the three months ended in Nov. 2024 was $0.36 Mil. Rapid Dose Therapeutics's Total Assets for the quarter that ended in Nov. 2024 was $1.23 Mil. Therefore, Rapid Dose Therapeutics's Asset Turnover for the quarter that ended in Nov. 2024 was 0.29.

Asset Turnover is linked to ROE % through Du Pont Formula. Rapid Dose Therapeutics's annualized ROE % for the quarter that ended in Nov. 2024 was 137.30%. It is also linked to ROA % through Du Pont Formula. Rapid Dose Therapeutics's annualized ROA % for the quarter that ended in Nov. 2024 was -318.43%.

Rapid Dose Therapeutics Asset Turnover Historical Data

The historical data trend for Rapid Dose Therapeutics's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Asset Turnover Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Asset Turnover

Get a 7-Day Free Trial

0.02

0.19

0.51

0.26

0.49

Rapid Dose Therapeutics Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Asset Turnover	Get a 7-Day Free Trial															0.11	0.10	0.21	0.29	0.29

Competitive Comparison of Rapid Dose Therapeutics's Asset Turnover

For the Biotechnology subindustry, Rapid Dose Therapeutics's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Asset Turnover falls into.

Save Embed

;

Save Embed

;

Rapid Dose Therapeutics Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Rapid Dose Therapeutics's Asset Turnover for the fiscal year that ended in Feb. 2024 is calculated as

	Asset Turnover
=	Revenue	/	Average Total Assets
=	Revenue (A: Feb. 2024 )	/	( (Total Assets (A: Feb. 2023 )	+	Total Assets (A: Feb. 2024 ))	/ count )
=	0.756	/	( (1.67	+	1.396)	/ 2 )
=	0.756	/	1.533
=	0.49

Rapid Dose Therapeutics's Asset Turnover for the quarter that ended in Nov. 2024 is calculated as

	Asset Turnover
=	Revenue	/	Average Total Assets
=	Revenue (Q: Nov. 2024 )	/	( (Total Assets (Q: Aug. 2024 )	+	Total Assets (Q: Nov. 2024 ))	/ count )
=	0.359	/	( (1.257	+	1.195)	/ 2 )
=	0.359	/	1.226
=	0.29

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Rapid Dose Therapeutics (OTCPK:RDTCF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Rapid Dose Therapeutics's annulized ROE % for the quarter that ended in Nov. 2024 is

	ROE %^**		(Q: Nov. 2024 )
=	Net Income	/	Total Stockholders Equity
=	-3.904	/	-2.8435
=	(Net Income / Revenue)	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(-3.904 / 1.436)	*	(1.436 / 1.226)	*	(1.226/ -2.8435)
=	Net Margin %	*	Asset Turnover	*	Equity Multiplier
=	-271.87 %	*	1.1713	*	-0.4312
=	ROA %	*	Equity Multiplier
=	-318.43 %	*	-0.4312
=	137.30 %

Note: The Net Income data used here is four times the quarterly (Nov. 2024) net income data. The Revenue data used here is four times the quarterly (Nov. 2024) revenue data.

^** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Rapid Dose Therapeutics's annulized ROA % for the quarter that ended in Nov. 2024 is

	ROA %		(Q: Nov. 2024 )
=	Net Income	/	Total Assets
=	-3.904	/	1.226
=	(Net Income / Revenue)	*	(Revenue / Total Assets)
=	(-3.904 / 1.436)	*	(1.436 / 1.226)
=	Net Margin %	*	Asset Turnover
=	-271.87 %	*	1.1713
=	-318.43 %

Note: The Net Income data used here is four times the quarterly (Nov. 2024) net income data. The Revenue data used here is four times the quarterly (Nov. 2024) revenue data.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Rapid Dose Therapeutics Asset Turnover Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Asset Turnover

Comparable Companies

Traded in Other Exchanges

DOSE:Canada

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.